Stock List

Search by Ticker



Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX)
Stock Analysis

▲ 0.93%2.91

Stock Analysis

The following stock analysis is based on 10.4 years of data (i.e. since Nov 12, 2012). All the stock history has been downloaded.

Stock Exchange

Vertex Pharmaceuticals Incorpor trades on the NasdaqGS exchange in USD dollars.


It is in the sector.

Current Status of Vertex Pharmaceuticals Incorpor

It is currently trading at $315.07 ($312.16 the previous day).


The next reporting date is in 32 days (2023 05 03).

CNN estimates profits for the upcoming quarter will be $3.07 per share ($2.3B). The current Canada / US exchange rate is 1.3511.

Over the past 12 months, $0 worth of shares have been purchased and $101324670 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 14.1% per year assuming steady exponential growth. The actual 5 year average is 16.68. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year290.7286283950638.6+ Above Average
2 year209.83187042254-17.5- Below Average
3 year254.3538636363628.6+ Above Average
4 year197.7852809248614.2- Below Average
5 year173.1510305343519.5+ Above Average
Vertex Pharmaceuticals Incorpor is projected by analysts to get to $335.00 within the next 12 months (6.3%), but preticted targets range from as high as $440.00 (39.7%) and as low as $280(-11.1%).


The worst drop it has had in recent years is -49.1%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.

Stock shape test


With an average increase of 14.1% year over year, if Vertex Pharmaceuticals Incorpor is bought at the worst time, Stockmarketizer analysts estimate it will take 41.8 months before the stock will recover to the original purchase price. The P/E value is 24.18.

Tradingview BuySell Widget

Yahoo News Feed

This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors

Fri, 31 Mar 2023 13:00:00 Vertex Pharmaceuticals (NASDAQ: VRTX) has made a fortune developing medicines for cystic fibrosis (CF), a rare disease that causes damage to the lungs. The company is awaiting approval for exa-cel -- a therapy for the blood disorder sickle cell disease ...... Read Full Article

Have $2,000? 2 Exceptional Stocks to Buy In a Bear Market

Fri, 31 Mar 2023 11:45:00 The market has kept investors on a rollercoaster ride over the past year, and the choppy waters may continue for some time to come. No one can predict when smooth waters may be here to stay, particularly given the ongoing ...... Read Full Article

What Bear Market? These 2 Winning Stocks Are Still Worth Buying.

Thu, 30 Mar 2023 14:30:00 The stock market is in a precarious place. The sharp rise in both interest rates and bond yields has weighed heavily on most stocks since the first quarter of 2022. The top-shelf drugmakers Novartis (NYSE: NVS) and Vertex Pharmaceuticals (NASDAQ: VRTX) ...... Read Full Article

2 Top Stocks to Buy With $1,000 Right Now

Thu, 30 Mar 2023 14:00:00 Vertex Pharmaceuticals (NASDAQ: VRTX) may not be a household name like some healthcare companies, but this is a business that investors may be hard-pressed to overlook, bull or bear market. Vertex has a long history of profitability and revenue growth, ...... Read Full Article

2 No-Brainer Stocks to Buy Before the Next Bull Market

Thu, 30 Mar 2023 13:53:00 While no one can predict when the next prolonged bull move will appear, the stock market has proven time and again its ability to rebound from even the most dire periods of volatility. Vertex Pharmaceuticals (NASDAQ: VRTX) has continued to ...... Read Full Article

2 No-Brainer Growth Stocks to Buy and Hold for Years

Thu, 30 Mar 2023 13:40:00 A long-term investment in these highly profitable businesses could pay off in manifold returns over the next 5 to 10 years.... Read Full Article

Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie

Wed, 29 Mar 2023 18:00:00 Vertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market. Vertex and AbbVie also happen to offer a lot of growth potential. Vertex has a new potential blockbuster drug on the horizon.... Read Full Article

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

Mon, 27 Mar 2023 21:50:09 In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $308.47, marking a -1.88% move from the previous day.... Read Full Article

IBD 50 Stocks To Watch: Vertex Pharmaceuticals Nears Buy Point; Institutions Scoop Up Shares

Mon, 27 Mar 2023 17:31:44 Vertex Pharmaceuticals is forming a base and back above its 50-day moving average. VRTX stock ranks third out of 792 biotechs.... Read Full Article

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock Has Fared Decently: Is the Market Following Strong Financials?

Mon, 27 Mar 2023 12:00:40 Vertex Pharmaceuticals' (NASDAQ:VRTX) stock is up by 9.4% over the past three months. Since the market usually pay for...... Read Full Article

Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes

Mon, 27 Mar 2023 12:00:00 BOSTON and ZUG, Switzerland, March 27, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene editing technology, known as CRISPR/Cas9, ...... Read Full Article

Want $1 Million in Retirement? Buy and Hold These 5 Stocks

Sun, 26 Mar 2023 09:54:00 There's no guarantee that you'll be a millionaire retiree. But these stocks could improve your odds.... Read Full Article

Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend

Sat, 25 Mar 2023 09:41:00 The past 15 months haven't been easy for growth stock investors. The Nasdaq Composite index has fallen a disappointing 25% since the beginning of 2022, making this an unusually long bear market. You don't need an economics degree to see that every bear ...... Read Full Article

Semiconductor Plays Dominate This Screen Of 21 Stocks To Watch

Thu, 23 Mar 2023 15:30:07 The best stocks to watch often hail from the top-ranked industries. Here's a look at 21 such stocks, including AMAT, AVGO and MBLY.... Read Full Article

Halozyme Therapeutics (HALO) Down 34.4% Since Last Earnings Report: Can It Rebound?

Thu, 23 Mar 2023 15:30:03 Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.... Read Full Article

This Cathie Wood Stock Could Nearly Double, According to Wall Street

Thu, 23 Mar 2023 14:07:00 One stock that could ride the market rally is CRISPR Therapeutics (NASDAQ: CRSP). This biotech is seeking to develop breakthrough therapies for difficult-to-treat illnesses using gene editing, and the company's focus in this area earned it a prominent place in ...... Read Full Article

This Is My Highest-Conviction Stock to Own in 2023 and Beyond

Thu, 23 Mar 2023 11:45:00 While one could say the same about many biotech companies, Vertex has an advantage very few of its peers do: For CF patients, it's the only game in town. Vertex markets the only medicines that target the underlying causes of ...... Read Full Article

Got $3,000? 3 Growth Stocks to Double Up on Right Now

Thu, 23 Mar 2023 09:50:00 If you've got $3,000, here are three growth stocks to double up on right now. Amazon (NASDAQ: AMZN) has gotten off to a great start this year, with shares jumping around 16%. There are two main reasons behind Amazon's weak stock performance.... Read Full Article

Here's Why You Should Add CRISPR Stock to Your Portfolio

Tue, 21 Mar 2023 15:59:03 CRISPR Therapeutics (CRSP), a top-ranked stock at present, is developing its lead pipeline candidate to treat TDT and SCD.... Read Full Article

The Best Stocks to Invest $20,000 in Right Now

Tue, 21 Mar 2023 09:50:00 Critics of Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) believe that the company is lagging behind OpenAI and Microsoft in the artificial intelligence (AI) race. It could be a huge mistake to underestimate Alphabet's AI expertise or Google Search's resilience.... Read Full Article